Literature DB >> 15740103

Multicomponent cycloadditions: the four-component [5+1+2+1] cycloaddition of vinylcyclopropanes, alkynes, and CO.

Paul A Wender1, Gabriel G Gamber, Robert D Hubbard, Son M Pham, Lei Zhang.   

Abstract

Prompted by the view that intermediates of transition metal-catalyzed reactions could be intercepted by one or more additional components, studies in our laboratory have led to the design and development of new three-component [5+2+1], [4+2+1], and [2+2+1] cycloadditions. These continuing studies have now led to the identification of a fundamentally new four-component [5+1+2+1] cycloaddition reaction of vinylcyclopropanes, alkynes and CO, yielding hydroxyindanone products in generally good yields. Terminal alkynes bearing aryl or alkyl groups are tolerated well. Substitution at any position of the VCP leads predictably to substituted hydroxyindanone products. Using a bis-alkynyl substrate, the reaction can be carried out bi-directionally, forming 10 C-C bonds and four new rings from seven components in a single, operationally simple process.

Entities:  

Year:  2005        PMID: 15740103     DOI: 10.1021/ja042728b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

2.  Four-component domino reaction providing an easy access to multifunctionalized tricyclo[6.2.2.0(1,6)]dodecane derivatives.

Authors:  Bo Jiang; Chao Li; Feng Shi; Shu-Jiang Tu; Parminder Kaur; Walter Wever; Guigen Li
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

3.  Mechanism and Reactivity of Rh-Catalyzed Intermolecular [5+1] Cycloaddition of 3-Acyloxy-1,4-Enyne (ACE) and CO: A Computational Study.

Authors:  Xiao-Na Ke; Casi M Schienebeck; Chen-Chen Zhou; Xiufang Xu; Weiping Tang
Journal:  Chin Chem Lett       Date:  2015-03-27       Impact factor: 6.779

4.  Domino constructions of pentacyclic indeno[2,1-c]quinolines and pyrano[4,3-b]oxepines by [4+1]/[3+2+1]/[5+1] and [4+3] multiple cyclizations.

Authors:  Bo Jiang; Bao-Ming Feng; Shu-Liang Wang; Shu-Jiang Tu; Guigen Li
Journal:  Chemistry       Date:  2012-07-05       Impact factor: 5.236

5.  Asymmetric synthesis of α-amino-1,3-dithianes via chiral N-phosphonyl imine-based Umpolung reaction without using chromatography and recrystallization.

Authors:  Padmanabha V Kattamuri; Teng Ai; Suresh Pindi; Yinwei Sun; Peng Gu; Min Shi; Guigen Li
Journal:  J Org Chem       Date:  2011-03-15       Impact factor: 4.354

6.  Rh(I)-catalyzed Pauson-Khand-type cycloaddition reaction of ene-vinylidenecyclopropanes with carbon monoxide (CO).

Authors:  Wei Yuan; Xiang Dong; Min Shi; Patrick McDowell; Guigen Li
Journal:  Org Lett       Date:  2012-10-25       Impact factor: 6.005

7.  Synthesis and palladium-catalysed isomerisation of fused polycyclic tetrahydrofurans: efficient and stereoselective one-pot domino construction of functionalised bridged bicyclo[n.2.1] ring systems.

Authors:  Pierre-Yves Roger; Fabien Blondeau; David Bensa; Thierry Constantieux; Jean Rodriguez
Journal:  Mol Divers       Date:  2009-03-13       Impact factor: 2.943

8.  Synthetic studies and mechanistic insight in nickel-catalyzed [4+2+1] cycloadditions.

Authors:  Yike Ni; John Montgomery
Journal:  J Am Chem Soc       Date:  2006-03-01       Impact factor: 15.419

9.  Rhodium-catalyzed tandem annulation and (5 + 1) cycloaddition: 3-hydroxy-1,4-enyne as the 5-carbon component.

Authors:  Xiaoxun Li; Wangze Song; Weiping Tang
Journal:  J Am Chem Soc       Date:  2013-10-31       Impact factor: 15.419

10.  Asymmetric C-C Bond Formation between Chiral N-Phosphonyl Imines and Ni(II)-Complex of Glycine Schiff Base Provides a GAP Synthesis of α,β-syn-Diamino Acid Derivatives.

Authors:  Hao Sun; Haowei Zhang; Jianlin Han; Yi Pan; Guigen Li
Journal:  European J Org Chem       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.